Neoplasms

A novel PET radiotracer can accurately assess the presence of a biomarker that indicates the level of tumor aggressiveness in neuroendocrine neoplasms (NENs). According to research published in the September issue of The Journal of Nuclear…

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 15, 2022 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has initiated a Phase I trial in China of HMPL-A83, an…

Key findings from evaluation of 59 Heme Samples and 10 Controls: OGM detected 162/164 SVs detected by standard cytogenetics methods of karyotyping and FISHOGM detected chromosomal aberrations missed by karyotyping and FISH in 35…